SUVEN PHARMACEUTICALS
Back to All Ratios
|
SUVEN PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 13.44 | 13.94 | 18.04 | 19.36 | 15.48 |
What is the latest Cash Earnings per Share (CEPS) ratio of SUVEN PHARMACEUTICALS ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 13.44 |
| Mar2024 | 13.94 |
| Mar2023 | 18.04 |
| Mar2022 | 19.36 |
| Mar2021 | 15.48 |
How is Cash Earnings per Share (CEPS) of SUVEN PHARMACEUTICALS Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 13.44 | -3.59 | |
| Mar2024 | 13.94 | -22.73 | |
| Mar2023 | 18.04 | -6.82 | |
| Mar2022 | 19.36 | 25.06 | |
| Mar2021 | 15.48 | - | |
Other Financial Ratios of SUVEN PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹21,745.1 Cr | -2.3% | -33.2% | -56.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,044.0 Cr | 1.5% | 6.5% | -1.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,877.0 Cr | 0.8% | 0.3% | 6.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,042.0 Cr | 1% | 4.4% | 18.1% | Stock Analytics | |
| CIPLA | ₹123,060.0 Cr | -0.4% | -3.8% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,190.0 Cr | 0.1% | -2.8% | 1.8% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -2.3% |
-33.2% |
-56.7% |
| SENSEX | 0.5% |
1.7% |
11% |
You may also like the below Video Courses